Levetiracetam Ratiopharm

Levetiracetam, the active ingredient in Levetiracetam Ratiopharm, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. With a robust distribution network, GNH USA ensures timely delivery and supports customers with technical and regulatory assistance.

Levetiracetam is an antiepileptic medication used to control seizure activity in various epilepsy syndromes.

- Partial‑onset seizures: reduces the frequency and severity of focal seizures in patients with epilepsy, improving daily functioning. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy, contributing to seizure freedom for many patients. - Myoclonic seizures: decreases myoclonic jerks in appropriate seizure types, aiding control of rapid, brief muscle contractions. - Adjunct therapy: can be used alongside other antiepileptic drugs to enhance overall seizure control.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach, sometimes with vomiting. - Somnolence: excessive sleepiness during the day.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or severe anxiety. - Hematologic abnormalities: low blood cell counts, such as leukopenia. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust dose in patients with reduced kidney function. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Pregnancy: limited data; weigh potential benefits against unknown risks. - Elderly patients: start with lower dose and monitor tolerability. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam has a relatively low interaction profile, but certain drug combinations require attention.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy. - Phenobarbital: can lower levetiracetam concentrations, potentially compromising seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring dose adjustment. - Alcohol: additive CNS depression may enhance dizziness or somnolence. - Other antiepileptics (e.g., phenytoin, lamotrigine): monitor for altered seizure control. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception.